DETAILED NOTES ON BLOCK PAIN RECEPTORS WITH PROLEVIATE

The activation of CB1 and CB2 inhibits the formation of intracellular cAMP, therefore leading to a huge reduction of the excitatory outcome within the neurons [88,89]. Moreover, the activation of CB2 can more protect against the mast cell degranulation and the release of professional-inflammatory mediators, building the reduction in pain sensation